Rotz L.

Understanding the evolving social media preferences of healthcare professionals (HCPs) is crucial for pharmaceutical companies looking to leverage these platforms for disseminating clinical information. While Medical Affairs teams have somewhat recently begun using Twitter/X for scientific exchange, brand safety uncertainties in 2023 have sparked interest in HCPs' behavioral changes on social media. This webinar will explore trends on X and other platforms to identify potential shifts in preferred channels for scientific communication.

Questions We Addressed:

  • Do HCPs see social media platforms as valuable channels for clinical information?

  • Are HCPs sharing as much content with their peers on X compared to previous years?

  • Are digital opinion leaders leaving X for other platforms?

  • What conversations are happening—both by HCPs and pharmaceutical organizations—around the potential of an X replacement?

Watch the Webinar